Ledger.Open graph →
SEC Form D · filed August 25, 2025

X4 Pharmaceuticals, Inc

Offering
$85.0M
Sold
$85.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Mary Dibiase · BOSTON, MAExecMurray W. Stewart · BOSTON, MADirectorDavid Kirske · BOSTON, MAExecMichael S. Wyzga · Waltham, MADirectorFrancoise J. De Craecker · BOSTON, MADirectorGary J. Bridger · Laval, Quebec, CanadaDirectorAdam Craig · BOSTON, MAExec · DirectorChristophe Arbet-Engels · BOSTON, MAExecJohn Volpone · BOSTON, MAExecMark Baldry · Boston, MAExecMary Dibiase · BOSTON, MAExecMurray W. Stewart · BOSTON, MADirectorChristophe Arbet-Engels · BOSTON, MAExecDavid Kirske · BOSTON, MAExecMichael S. Wyzga · Waltham, MADirectorJohn Volpone · BOSTON, MAExecMark Baldry · Boston, MAExecFrancoise J. De Craecker · BOSTON, MADirectorGary J. Bridger · Laval, Quebec, CanadaDirectorAdam Craig · BOSTON, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗